Cordani David's Form 4 filing
Cigna Group (CI) · filed Mar 1, 2022
- Accession no.
- 0001225208-22-003747
- Filed
- Mar 1, 2022
- Trade date
- Feb 25-28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $2.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cordani DavidCIK 0001318751 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 | Common Stock, $.01 Par Value | AGrant or awardAcquired | +18,766 | $0.00 | $0 | 171,518 | Direct | |
| Feb 25, 2022 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −5,006 | $229.64 | −$1,149,577.84 | 166,512 | Direct | |
| Feb 25, 2022 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −8,697 | $229.64 | −$1,997,179.08 | 157,815 | Direct | |
| Feb 28, 2022 | Common Stock, $.01 Par Value | SSaleDisposed | −10,069 | $228.70 | −$2,302,780.3 | 147,746 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.